載入...
Effects of Erythropoietin-Stimulating Agents on Blood Pressure in Patients with Non-Dialysis CKD and Renal Anemia
INTRODUCTION: Erythropoietin-stimulating agents (ESAs) are used to treat renal anemia in patients with non-dialysis CKD, but this can lead to increases in blood pressure (BP). OBJECTIVE: We investigated the effects of continuous erythropoietin receptor activator (CERA) and darbepoetin alfa (DA) on o...
Na minha lista:
| 發表在: | Kidney Dis (Basel) |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
S. Karger AG
2020
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7445655/ https://ncbi.nlm.nih.gov/pubmed/32903814 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000507396 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|